Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Traws Pharma (TRAW) over the last 13 years, with Q3 2025 value amounting to $407646.0.

  • Traws Pharma's Non-cash Items fell 7453.96% to $407646.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $407646.0, marking a year-over-year decrease of 7453.96%. This contributed to the annual value of $2.7 million for FY2024, which is 18046.67% up from last year.
  • Traws Pharma's Non-cash Items amounted to $407646.0 in Q3 2025, which was down 7453.96% from $263000.0 recorded in Q2 2025.
  • Traws Pharma's 5-year Non-cash Items high stood at $2.7 million for Q4 2024, and its period low was $21000.0 during Q4 2023.
  • In the last 5 years, Traws Pharma's Non-cash Items had a median value of $406320.0 in 2025 and averaged $742287.6.
  • In the last 5 years, Traws Pharma's Non-cash Items tumbled by 9537.89% in 2021 and then surged by 1274761.9% in 2024.
  • Over the past 5 years, Traws Pharma's Non-cash Items (Quarter) stood at $24261.0 in 2021, then skyrocketed by 858.28% to $232488.0 in 2022, then tumbled by 90.97% to $21000.0 in 2023, then soared by 12747.62% to $2.7 million in 2024, then crashed by 84.89% to $407646.0 in 2025.
  • Its Non-cash Items stands at $407646.0 for Q3 2025, versus $263000.0 for Q2 2025 and $406320.0 for Q1 2025.